EssilorLuxottica (OTCMKTS:ESLOY) Stock Passes Above 50 Day Moving Average – Here’s Why

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY)’s stock price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $98.09 and traded as high as $100.13. EssilorLuxottica shares last traded at $99.91, with a volume of 68,396 shares changing hands.

Analyst Upgrades and Downgrades

ESLOY has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft assumed coverage on EssilorLuxottica in a research report on Tuesday, May 12th. They set a “hold” rating for the company. Zacks Research cut EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 23rd. Finally, The Goldman Sachs Group downgraded EssilorLuxottica from a “buy” rating to a “hold” rating in a report on Tuesday, July 14th. Two analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, EssilorLuxottica presently has an average rating of “Moderate Buy”.

EssilorLuxottica Trading Up 1.0%

The business has a fifty day moving average of $98.09 and a two-hundred day moving average of $114.98. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.